| Literature DB >> 23090023 |
Mohamed Mustafa Ibrahim1, Hapipah Mohd Ali, Mahmood Ameen Abdullah, Pouya Hassandarvish.
Abstract
The present study was performed to evaluate the gastroprotective activity of Schiff base ligand derived from the condensation reaction of tryptamine (an indole derivative) and 5-nitrosalicylaldehyde (TNS) and its nickel (II) complex against ethanol-induced gastric ulcer in rats. The compounds were orally administered with low (30 mg/kg) and high (60 mg/kg) doses to ulcer-induced Sprague-Dawley rats. Macroscopically, the ulcer control group exhibited severe mucosal injury, whereas pre-treatment with either cimetidine or TNS and its nickel (II) complex each resulted in significant protection against gastric mucosal injury. Flattening of gastric mucosal folds was also observed in rats pretreated with TNS and its nickel complex. Histological studies of the gastric wall of ulcer control group revealed severe damage of gastric mucosa, along with edema and leucocytes infiltration of the submucosal layer compared to rats pre-treated with either cimetidine or TNS and its nickel (II) compound, where there was marked gastric protection along with reduction of edema and leucocytes infiltration of the submucosal layer. Acute toxicity study done on mice with a higher dose of 5 g/kg of TNS and its nickel (II) complex did not manifest any toxicological signs. Research finding suggest that TNS and its nickel (II) complex could be considered as effective gastroprotective compounds.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23090023 PMCID: PMC6268460 DOI: 10.3390/molecules171012449
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Scheme 1Reaction routes.
Effect of TNS and its nickel (II) complex on ulcer area, mucus weight, pH and inhibition percentage in rats.
| Compound | Total ulcer area (mm2) | Mucus weight (g) | pH | % Inhibition |
|---|---|---|---|---|
| (Mean ± S.E.M) | ||||
| Tween-20 | 1438 ± 58 a | 0.58 ± 0.05 | 2.00 ± 0.01 | - |
| (ulcer control) | ||||
| Cimetidine | 168 ± 5 b | 0.61 ± 0.05 | 3.00 ± 0.01 | 88 |
| (+ve control) | ||||
| TNS (HD) | 3.6 ± 0.2 c | 1.33 ± 0.05 | 4.22 ± 0.01 | 100 |
| TNS (LD) | 3.6 ± 0.2 c | 1.60 ± 0.05 | 4.11 ± 0.01 | 100 |
| (TNS)2Ni (HD) | 7.2 ± 0.3 d | 1.65 ± 0.05 | 3.68 ± 0.01 | 96 |
| (TNS)2Ni (LD) | 26.4 ± 0.2 d | 2.00 ± 0.05 | 3.05 ± 0.01 | 95 |
All values are expressed as mean ± standard error mean. Means with different superscripts are significantly different. The mean difference is significant at the p < 0.05 level. HD: High dose: 60 mg/kg, LD: Low dose: 30 mg/kg.
Figure 1(a) Macroscopic appearance of the gastric mucosa in a rat pre-treated with 10 ml/kg of 10% Tween-20 (ulcer control). Severe hemorrhagic mucosal lesions are seen in the gastric mucosa. (b) Macroscopic appearance of the gastric mucosa in a rat pre-treated with Cimetidine (50 mg/kg). Injuries to the gastric mucosa are milder compared to the injuries seen in the ulcer control rat. (c) Macroscopic appearance of the gastric mucosa in a rat pre-treated with TNS (60 mg/kg). No injuries to the gastric mucosa are seen, and showed flattening of gastric mucosa.
Figure 2(a) Histological section of gastric mucosa in a rat pre-treated with 10 ml/kg of 10% Tween-20 (ulcer control) only. There is severe disruption to the surface epithelium, and edema of the submucosal layer with leucocyte infiltration. (b) Histological section of gastric mucosa in a rat pre-treated with 10 ml/kg of Cimetidine (50 mg/kg). There is mild disruption to the surface epithelium with mild edema and leucocytes infiltration of the submucosal layer. (c) Histological section of gastric mucosa in a rat pre-treated with 10 ml/kg of TNS (60 mg/kg). There is no disruption to the surface epithelium with no edema and no leucocytes infiltration of the submucosal layer.